​

InMed Pharmaceuticals Ownership | Who Owns InMed Pharmaceuticals?

OverviewRevenueFinancialsChart

InMed Pharmaceuticals Ownership Summary

InMed Pharmaceuticals is owned by 0.34% insiders, and 99.66% retail investors. AdvisorShares Pure Cannabis ETF is the top mutual fund, with 1.36% of its assets in InMed Pharmaceuticals shares.

INM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockInMed Pharmaceuticals-0.34%99.66%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-91.67%27-100.00%----100.00%--100.00%
Sep 30, 202411-8.33%1,113,450152.90%-0.86%775.00%1-66.67%
Jun 30, 202412-25.00%440,278-35.81%46.19%4-20.00%3-
Mar 31, 2024166.67%685,866-14.72%88.45%5-44.44%350.00%
Dec 31, 20231566.67%804,2502893.45%10837.71%950.00%2-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
AdvisorShares Pure Cannabis ETF16.43K1.36%-

Recent Insider Transactions

DateNameRoleActivityValue
Jul 31, 2024MANCINI ALEXANDRA DIANE JANET ConsultantSell$42.31
Feb 21, 2024HULL ANDREW-Buy$14.63K
Feb 20, 2024ADAMS ERIC A President & CEOBuy$14.92K
Apr 14, 2022ADAMS ERIC A President & CEOBuy$12.66K
Apr 13, 2022ADAMS ERIC A President & CEOBuy$7.28K

Insider Transactions Trends

DateBuySell
2024 Q3-1
2024 Q2--
2024 Q12-
2023 Q4--
2023 Q3--

INM Ownership FAQ

Who Owns InMed Pharmaceuticals?

InMed Pharmaceuticals shareholders are primarily institutional investors at 0%, followed by 0.34% insiders and 0% retail investors. The average institutional ownership in InMed Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which InMed Pharmaceuticals falls below.

Does Blackrock own InMed Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of InMed Pharmaceuticals.

Who is the top mutual fund holder of InMed Pharmaceuticals shares?

AdvisorShares Pure Cannabis ETF is the top mutual fund holder of InMed Pharmaceuticals shares, with 1.36% of its total shares outstanding invested in 16.43K InMed Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools